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Introduction
Papillary thyroid cancer (PTC) has the peculiar tendency 
to spread to central and lateral neck lymph nodes. PTC 
recurrences typically involve cervical lymph nodes in 
60–75% of cases, with the central compartment being the 
most frequently involved site (1-3). While no controversy 
exists on the role of therapeutic central lymph node dissection 
(CND), concomitant with thyroidectomy or as a revision 
procedure, elective CND is still a debated issue. Indeed, 
the American Thyroid Association (ATA) guidelines (4) do 
not help in the controversy on elective treatment of level 
VI, due to an unclear prognostic role and a non-negligible 
rate of complications. The debate on morbidity of CND 
is prevalently focused on injury, transient or permanent, to 
the recurrent laryngeal nerve (RLN) and/or parathyroid 
glands. Chyle leakage is rare, and data in the literature are 
consequently scarce. No specific data have been reported on 
other complications such as hematoma, vascular or visceral 
injury, and wound infection.
There are important differences in the surgical technique 
and complication rate between CND associated with total 
thyroidectomy (TTCND) and revision CND (RCND); for 
this reason, we will provide a separate discussion for the two 
topics.
Surgical boundaries of the central neck 
compartment 
The ATA consensus statement regarding the terminology 
and classification of the central neck (5,6) states that the 
CND contains the perithyroidal and paratracheal soft 
tissues as well as lymph nodes; it is limited superiorly by 
the hyoid bone, laterally by the common carotid arteries, 
anteriorly the by the superficial layer of the deep cervical 
fascia (and posterior aspect of the infrahyoid muscles), 
posteriorly by the deep layer of the cervical fascia (covering 
the prevertebral muscles and the oesophagus), and inferiorly 
by sternum and the innominate artery. The term CND, 
as defined by the ATA consensus, implies removal of 
prelaryngeal and pretracheal lymphatic tissue and at least 
one paratracheal lymph node. This is defined as unilateral 
CND, whereas in bilateral CND paratracheal nodes on 
both sides are removed (5,6).
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Complications in CND associated with 
thyroidectomy
In recent years, the “pros” and “cons” of elective central 
compartment neck dissection were thoroughly analyzed 
but a significant disputation still remains: several authors, 
indeed, have suggested routine use of elective CND in 
differentiated thyroid carcinomas (7-10). On the other 
hand, despite the high prevalence of lymph node micro-
metastases from PTC (ranging from 38% to 61%) (1,3,11), 
several investigators (11-15) have outlined the limits of such 
an approach, with a significant increase in the morbidity 
associated with standard total thyroidectomy and no 
differences in overall and disease specific survival.
One of the main reasons that led several authors to 
consider elective CND is the low accuracy of preoperative 
diagnostic tools in identifying nodal involvement at this 
level, especially when dealing with recurrent disease (16). 
Indeed, while neck ultrasonography (US) and cross-sectional 
imaging techniques, such as computed tomography (CT) 
and magnetic resonance imaging (MRI), reliably evaluate 
lateral neck levels, they are less accurate in the assessment 
of the central compartment. Several studies have reported 
a low sensitivity of US and CT, with values ranging from 
51% to 67%, and from 62% to 66%, respectively (17,18); 
this is due to the fact that lymph nodes are often small and 
located deeply in the neck, or just posterior to the sternum, 
thus hindering adequate visualization (13,19-21). 
In 2006, the European Consensus Statement (22) 
emphasized that the benefits of elective CND in the absence 
of pre- or intraoperative evidence for nodal disease are 
controversial: in fact, there is no evidence that it decreases 
the rate of either recurrence or mortality; conversely, 
it may allow accurate staging of the disease that can 
modulate subsequent treatments and follow-up. Similarly, 
recommendations in the 2015 American Guidelines (4) are 
not clear-cut. Recommendation #36 suggests elective CND 
(ipsilateral or bilateral) in patients with PTC with clinically 
uninvolved central neck lymph nodes (cN0) and advanced 
primary tumors (T3 or T4) or clinically involved lateral 
neck nodes (cN1b), or if the information might be used to 
plan further steps in therapy (4).
Most authors agree with the observation that TTCND 
leads to a higher risk of complications when compared 
with total  thyroidectomy alone, particularly with 
regards to hypoparathyroidism (HPT) rather than RLN 
injury (11,12,17,23-29). In fact, the RLN at the end of 
thyroidectomy is already exposed, visible, and only its most 
caudal part needs to be further dissected (17,25-27,29,30). 
For this reason, intraoperative nerve monitoring (IONM), 
despite its importance in the thyroidectomy phase, does not 
seem to play such an important role in RLN preservation 
during the CND phase (31). However, it is worth 
remembering that IONM may be helpful in identifying a 
loss of signal on the first side that could suggest to stage 
completion thyroidectomy, especially in case of non-
aggressive thyroid cancer.
In the literature, the rate of transient RLN injury 
and HPT ranges from 0% to 7.3%, and from 8.7% to 
86%, respectively (11,12,15,23,30,32). Furthermore, the 
reported rates of permanent unintentional RLN injury 
and permanent HPT ranges from 0% to 5.9%, and from 
0% to 16.2%, respectively (Table 1). Different authors 
suggested that the rate of complications in patients treated 
with TTCND may be overestimated (15,32,47,48). In a 
pivotal paper by Giordano and colleagues (7), a comparative 
study on 1,087 patients affected by PTC with clinically 
negative lymph nodes was performed. Patients were divided 
in three homogeneous groups: patients treated with total 
thyroidectomy alone, unilateral TTCND, and bilateral 
TTCND. Overall, the results of the three groups were 
comparable to those reported in the literature: indeed, 
rates of transient RLN injury and HPT were 4.2% and 
37.5%, respectively. Regarding permanent complications, 
the rates of RLN injury and HPT were 1.2% and 9.4%, 
respectively. The analysis comparing the three groups 
showed that neither unilateral nor bilateral TTCND were 
associated with a significantly increased rate of transient 
or permanent RLN injury. On the other hand, the rate of 
transient HPT was significantly higher in both unilateral 
and bilateral TTCND. Finally, the rate of permanent 
HPT was significantly increased in case of bilateral, but 
not unilateral, TTCND. These results were consistent 
with those reported in other studies (11,12,17,23-29). 
The increased rate of permanent HPT in bilateral 
TTCND may be due to the increased risk of traumatic 
and ischemic damage to parathyroid glands caused by 
surgical manipulation (7,30,49); therefore, it is strongly 
suggested to make every effort to preserve the vascular 
supply to the superior parathyroid gland. On the contrary, 
it may be more technically demanding to avoid ischemic 
injuries to the inferior parathyroid gland (1,7,11,25). It 
is worth mentioning that several authors demonstrated 
no significant effect on postoperative HPT in case of 
intraoperative ligation of the inferior thyroid artery (ITA) 
(50-53), although the preservation of the inferior thyroidal 
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vein (ITV) seems to reduce postoperative hypocalcemia (54). 
In two papers, this finding was ascribed to a damage caused 
by insufficient blood discharge to whom a parathyroid 
is exposed if the ITV is sacrificed far from the thyroid 
parenchyma during CND (54,55).
Nevertheless, the inferior parathyroid gland can be 
removed and, after intraoperative histologic confirmation by 
frozen sections, re-implanted as an autograft in the sternal 
belly of the sternocleidomastoid muscle. Indeed, both 
Smith et al. (56) and Shaha et al. (57) showed conclusive data 
on the efficacy of parathyroid autotransplantation to reduce 
the risk of postoperative HPT when aggressive dissection, 
or vascular injury to the parathyroids, is performed.
Since the risk of central compartment involvement is 
mainly on the same side of the tumor (58) and contralateral 
metastases, conversely, are rare without ipsilateral positive 
Table 1 Review of the literature showing the rate of surgical complications after TTCND
Author Year N Transient RLN palsy (%) Permanent RLN palsy (%) Transient HPT (%) Permanent HPT (%)
Henry (12) 1998 50 4.0 0 14.0 4.0
Steinmuller (33) 1999 53 3.8 1.9 39.6 1.9
Pereira (14) 2005 43 0 7.0 60.0 4.6
Sywak (11) 2006 56 1.8 0 17.9 1.8
Lee (15) 2007 78 0 ipsilateral 0 ipsilateral 20.5 ipsilateral 0 ipsilateral
25 0 bilateral 0 bilateral 48 bilateral 0 bilateral
Roh (25) 2007 82 7.3 3.6 30.5 4.9
Palestini (27) 2008 93 5.4 ipsilateral 0 ipsilateral 27.0 ipsilateral 0 ipsilateral
64 7.8 bilateral 0 bilateral 31.0 bilateral 0 bilateral
Choi (34) 2008 48 2.1 0 16.7 0
Rosenbaum (29) 2009 22 – 0 86.0 5.0
Perrino (35) 2009 92 2.7 1.5 8.7 1.5
Hughes (36) 2010 78 – 0 26.9 0
Moo (37) 2010 45 8.9 0 31.1 2.6
Popadich (38) 2011 259 0.4 0.4 9.6 0.8
Giordano (7) 2012 385 3.9 ipsilateral 0.5 ipsilateral 36.1 ipsilateral 7.0 ipsilateral
308 5.5 bilateral 2.3 bilateral 51.9 bilateral 16.2 bilateral
Lang (8) 2012 82 1.8 0.6 18.3 2.4
So (39) 2012 119 3.4 0.8 41.2 5.9
Raffaelli (40) 2012 62 1.6 ipsilateral 1.6 ipsilateral 25.8 ipsilateral 0 ipsilateral
62 0 bilateral 0 bilateral 56.4 bilateral 1.6 bilateral
Wang (41) 2012 49 – 2.0 42.9 0
Barczynski (42) 2013 358 7.3 2.5 30.4 2.2
Calo (43) 2014 65 3.1 0 38.5 10.8
De Carvalho (44) 2015 102 11.8 5.9 46.1 11.8
Lee (45) 2015 153 3.3 1.3 36.6 3.3
Calo (46) 2017 30 3.3 ipsilateral 0 ipsilateral 23.3 ipsilateral 3.3 ipsilateral
30 0 bilateral 0 bilateral 36.7 bilateral 3.3 bilateral
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nodes, several authors have recommended to perform 
TTCND ipsilateral to the tumor in case of differentiated 
thyroid carcinomas, thus finding a reasonable balance 
between morbidity and oncologic outcome (7-10). 
The results presented by Giordano and colleagues (7), 
were also confirmed in a recent meta-analysis published 
by Zhao et al. (59). Patients who underwent TTCND 
with elective intent had a significantly increased risk of 
postoperative hypocalcemia than patients who underwent 
tota l  thyroidectomy a lone,  inc luding temporary 
hypocalcemia (28.7% vs. 17.5%, OR =2.37), and permanent 
hypocalcemia (4.1% vs. 2.3%, OR =1.93). On the other 
hand, the risk of temporary and permanent RLN injury 
was confirmed to be similar in the two groups (OR =1.22 
and 1.17 respectively) (59). However, regarding overall 
complications, the meta-analysis indicated that the TTCND 
group has a significantly increased overall morbidity 
(OR =2.56), although it was similar after excluding 
temporary hypocalcemia (OR =1.14).
Chyle leakage is a rare complication of thyroid surgery, 
with or without CND, with an estimated prevalence of less 
than 1% (60-63). Lee et al. (61) retrospectively analyzed 
2,314 patients who underwent TTCND (unilateral or 
bilateral) for thyroid carcinoma: 14 (0.6%) patients were 
reported to have postoperative chyle leak, with a mean 
duration of the leakage of 4.3 days and a mean chyle 
volume of 53.2 mL/day. Before this paper, to the best of 
our knowledge, only a single case had been reported in the 
literature (60). All patients were treated conservatively by 
pressure dressings, a fat-free diet, and repeated percutaneous 
drainage. The authors ascribed the chyle leakage in patients 
who did not undergo lateral neck dissection to the presence 
of minor lymphatic ducts in the central compartment. 
These small ducts, when injured during dissection, may 
immediately collapse, and thus chyle leakage may be not 
intraoperatively detected. Due to its limited entity, chyle 
leak is commonly managed with conservative maneuvers 
and revision surgery is generally not required. 
Complications in revision CND 
Recurrent disease in the neck central compartment should 
be suspected in presence of lesions greater than 8 mm 
at US; these lesions should be considered for cytologic 
evaluation, Thyroglobulin aspirate rinsing analysis, and 
eventually, revision surgery (16). Surgery for recurrent 
disease in the central neck compartment is a complex 
procedure, and specific data regarding surgical morbidity 
are scarce, mainly as a result of the limited number of 
patients requiring RCND (64,65). 
Indications for revision surgery in central neck 
compartment include recurrent metastatic thyroid 
carcinoma to central compartment lymph nodes and 
inadequate initial surgery (5,66). RCND is technically 
demanding because of the abundant scar tissue and distorted 
anatomy, which may lead to a higher risk of injury to the 
RLN and parathyroid glands. RLN may be, indeed, in a less 
predictable location after thyroidectomy; in addition, the 
parathyroid glands and RLN may be encased within fibrotic 
tissue, making them indistinguishable from the tumor (16).
Central neck lymph node metastases are usually 
detected during follow-up by means of increased serum 
Thyroglobulin levels and by radiological examinations (US, 
radioactive iodine scan, or PET-CT), and subsequently 
confirmed with fine-needle aspiration cytology (FNAC) and 
contrast enhanced MRI or CT (18,21,67).
Several series have reported a higher incidence of 
permanent RLN palsy in RCND compared to primary 
setting procedures, with rates ranging from 1% to 12% 
(64,65,68-70). Regarding HPT, in RCND the parathyroid 
glands are at increased risk for devascularization or 
inadvertent removal. Several series (1,68,71-73) have 
reported an incidence of temporary and permanent HPT 
after revision surgery, ranging from 0.3% to 15%, and 
from 0% to 4.9%, respectively. Kim et al. (64) reported 
their experience of RCND on 20 patients. All patients had 
a normally preoperatively and postoperatively functioning 
larynx. Furthermore, 4 (20%) patients experienced transient 
postoperative HPT, with no evidence of permanent HPT. 
The authors emphasised the importance of a meticulous 
surgical dissection with identification of RLN in the 
lower part of tracheoesophageal groove, and the use of 
IONM. More recently, Cayonu et al. (65) retrospectively 
revised a single center series of 61 patients treated for 
central compartment lymph node recurrence from thyroid 
cancer. The authors suggested a step-by-step technique for 
identification and preservation of RLN and parathyroid 
glands. Interestingly, they did not routinely use IONM. 
They reported an acceptable rate of complications: 
temporary RLN palsy in 4 patients (6.6%), temporary 
HPT in 8 (13.1%), and permanent HPT in 3 (4.9%). No 
permanent RLN palsy, wound infection, or hematoma were 
reported.
Onkendi et al. (74) reported their experience in 410 
patients operated for recurrent PTC. One-hundred-twelve 
patients underwent unilateral and 107 bilateral CND (58% 
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of the series) with 80% of positive lymph nodes at definitive 
histologic examination. Unfortunately, an important 
limitation of the study is that the rate of complications is 
calculated on the whole series, including revision surgery 
on thyroid gland and lateral neck dissection: the overall 
complications rate was 6%, with 3% permanent HPT, and 
0.5% permanent RLN.
In general, IONM can be extremely useful because it 
facilitates the identification and dissection of the nerve in a 
surgical field with distorted landmarks, and may be helpful 
in predicting nerve function after surgery (16). Indeed, it 
is possible to map, with IONM’s probe, the area where the 
nerve might be located to avoid blind dissection. However, 
according to the results of a recent comparative analysis, 
the use of IONM in thyroid revision surgery does not seem 
to significantly reduce the risk of RLN palsy (31); careful 
dissection and visualization of the nerve remain of pivotal 
importance to minimize the risk of iatrogenic injury. The 
authors also stated that, in RCND, most problems are 
related to the difficult dissection of noble structures from 
scar tissue. In this sense, Alesina et al. (31) suggested that 
continuous monitoring could be very useful in minimizing 
the risk of injury.
Although in primary surgery preservation of the 
ITA does not seem, as already mentioned, to be great 
help in preventing postoperative HPT, Kim et al. (64) 
recommended preserving the artery in RCND to minimize 
the risk of devascularization of the parathyroid glands. 
However, great attention is commonly placed on the 
outcomes and usefulness of parathyroid autotransplantation. 
Indeed, to avoid postoperative HPT, several authors have 
recommended to carefully examine the specimen for 
parathyroid tissue by means of a histologic frozen section 
analysis (64,65,74). Reimplantation of the parathyroid 
gland(s) into the sternocleidomastoid muscle at the time of 
revision CND will decrease the risk of long-term permanent 
HPT (64). It is worth remembering that fibrosis and 
multiple positive lymph nodes in the dissected specimen can 
make identification and confirmation of parathyroid tissue 
very difficult. In patients with extensive extracapsular lymph 
node spread and multiple involved nodes, reimplantation 
can inadvertently lead to reimplantation of tumor along 
with parathyroid tissue (64). Notably, also in recurrent 
disease, in absence of bilateral central compartment 
involvement, it is preferable to avoid bilateral CND in 
order to minimize the risk of definitive HPT and bilateral 
RLN palsy (16).
As a last remark, the most important element in 
minimizing complications in thyroid surgery is the surgical 
volume of the surgeon, as widely reported in the literature 
(28,75,76). For this reason, Mazzaferri and colleagues (28) 
have properly stated that it is overall better, for the small 
minority of patients who subsequently develop central 
node metastasis to undergo therapeutic RCND by more 
experienced thyroid surgeons, than all patients undergo 
prophylactic dissection, with the majority being performed 
by less experienced surgeons.
Conclusions
Primary CND is associated with an acceptable rate of 
complications, since an increase of permanent HPT is 
reported when CND is performed bilaterally. Preservation 
of the vascular pedicle of the parathyroid glands, in 
particular the ITV, prevents ischemic damage. RCND 
for recurrent or persistent thyroid cancer is a challenging 
procedure even for the most experienced surgeon. Surgical 
dissection must be meticulous, with identification of 
the RLN and parathyroid glands. IONM may help in 
identifying the nerve in a fibrotic surgical field, thus 
minimizing the risk of iatrogenic damage. In both TTCND 
and RCND, parathyroid autotransplantation seems to 
contribute to prevention of postoperative HPT. Other 
complications, such as chyle leakage, are very rare and 
data in the current literature are scarce. Surgical volume 
remains the most important factor affecting the rate of 
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